Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
Risk Signals
9280 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Gsk Consumer Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-07-12 (bioworld.com)
Abbott and GSK to develop molecular diagnostic test for skin cancer treatment
Abbott and GSK to develop molecular diagnostic test for skin cancer treatment
Read more
2025-07-11 (vietnamnet.vn)
Mega-city status boosts Ho Chi Minh City's FDI appeal
Mega-city status boosts Ho Chi Minh City's FDI appeal
Read more
2025-07-10 (liveegy.com)
Urgent Warning from the Egyptian Pharmaceutical Authority: Clacified packages from "Uterrevin for adults" - Life Magazine | Live Magazine
Urgent warning from the Egyptian Pharmaceutical Authority: Clacified packages from "Uterrevin for adults" threatening the safety of citizens. The Egyptian Pharmaceutical Authority issued an important warning
Read more
2025-07-10 (powderbulksolids.com)
GSK to Close Skin Products Plant in Ireland, Cut 165 Jobs GSK to Close Skin Products Plant in Ireland, Cut 165 Jobs GSK to Close Skin Products Plant in Ireland, Cut 165 Jobs
UK-based drug maker GlaxoSmithKline plc plans to close its Stiefel Laboratories manufacturing plant for skin healthcare products in Sligo, Ireland by
Read more
2025-07-10 (isanidad.com)
GSK renews its agreement with the Ronald McDonald Children's Foundation to support families with hospitalized minors
GSK renews his collaboration with the Ronald McDonald Foundation to offer free accommodation to families with hospitalized children
Read more
2025-07-10 (bloomberg.com)
Court Sides With Zantac Makers GSK, Pfizer, Boehringer in Cancer Claims Suits - Bloomberg
The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product.
Read more
2025-07-10 (nasdaq.com)
GSK Starts Shipping Trivalent Flu Vaccines To U.S. Healthcare Providers For 2025-26 Season |
(RTTNews) - GSK plc (GSK, GSK.L) announced Thursday it has started shipping doses of its trivalent seasonal influenza vaccines to US healthcare providers and pharmacies in preparation for the 2025-26 flu season.
Read more
2025-07-09 (lifesciencereport.com)
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE Biotechnology's Ongoing Ovarian and Colorectal Cancer Trials -
Real-Time News, Market Data, and Stock Quotes for Life Science Stocks @ lifesciencereport.com
Read more
2025-07-09 (medicaldialogues.in)
GSK buys efimosfermin alfa from Boston Pharma for USD 2 billion
London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion deal.Efimosfermin is a phase III-ready, potential best-in-class investigational...
Read more
2025-07-09 (fiercepharma.com)
Respiratory pharma royalty rally around rural COPD education and support drive |
A who's who of respiratory disease drug developers has backed the American Lung Association's push to help chronic obstructive pulmonary disease (COPD) patients in rural communities.
Read more
2025-07-09 (ajbell.co.uk)
Daily market update: WPP, Jet2, drug companies, copper miners, tobacco sector and housebuilders | Wednesday 09 Jul 2025
"There was a solid showing across European equity markets despite Trump's tariff onslaught ramping up a gear," says Dan Coatsworth, investment analyst at AJ Bell. | Wednesday 09 Jul 2025
Read more
2025-07-09 (lesechos.fr)
Donald Trump releases the sulfater on pharmaceutical products, threatened by 200% customs duties |
The President threatens XXL customs duties laboratories on pharmaceutical products imported into the United States. Its signature recipe for forcing industrialists to move their factories on American soil. The Sanofi action is at the bottom of the CAC 40 ranking this Wednesday, but the market wonders about the reality of the threat.
Read more